{
  "main_header": {
    "sid": 493236,
    "name": "Genomic Valley",
    "stock_name": "Genomic Valley",
    "full_name": "Genomic Valley Biotech Ltd",
    "name_url": "stocks-analysis/genomic-valley",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "25.20",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "25.20",
    "mcapval": "8.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539206,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "indexname": "",
    "isin": "INE574D01010",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "852 ",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/genomic-valley-493236-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 12,
    "sid": "493236",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/genomic-valley-biotech-493236"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Jan-2026",
      "details": "Please find enclosed herewith unaudited financial results for the quarter and nine months ended on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 15-01-2026",
      "datetime": "15-Jan-2026",
      "details": "Please find enclosed herewith the Outcome of the Board Meeting dated 15/01/2026 for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter And Nine Month Ended 31St December 2025",
      "datetime": "15-Jan-2026",
      "details": "Please find enclosed herewith the financial results for the Quarter and Nine Months ended 31st December 2025 pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News